id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-1333-0008,FDA,FDA-2020-E-1333,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,,2022-08-29T17:33:11Z,,0,0,09000064852878dc
FDA-2020-E-1333-0007,FDA,FDA-2020-E-1333,Letter to U S Patent and Trademark Office,Other,Letter(s),2022-08-01T04:00:00Z,2022,8,2022-08-01T04:00:00Z,,2022-08-01T13:18:50Z,,0,0,09000064851f11a7
FDA-2020-E-1333-0006,FDA,FDA-2020-E-1333,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ADAKVEO",Notice,Determinations,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,2022-01-04T04:59:59Z,2021-11-09T19:41:11Z,2021-24070,0,0,0900006484e1b47a
FDA-2020-E-1333-0005,FDA,FDA-2020-E-1333,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-10-22T04:00:00Z,2021,10,2021-10-22T04:00:00Z,,2021-10-26T14:37:11Z,,0,0,0900006484de4388
FDA-2020-E-1333-0004,FDA,FDA-2020-E-1333,Patent Term Extension letter from Office of Patent Legal Administration to FDA CDER,Other,Letter(s),2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2021-07-26T17:03:12Z,,0,0,0900006484c0efd2
FDA-2020-E-1333-0003,FDA,FDA-2020-E-1333,Patent Term Extension letter from FDA CDER to The Honorable Andrei Lancu,Other,Extension of Time,2020-07-15T04:00:00Z,2020,7,2020-07-15T04:00:00Z,,2020-07-15T19:35:43Z,,0,0,090000648475b1a4
FDA-2020-E-1333-0001,FDA,FDA-2020-E-1333,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-05-01T04:00:00Z,2020,5,2020-05-01T04:00:00Z,,2020-05-01T17:42:06Z,,0,0,090000648452d699
FDA-2020-E-1333-0002,FDA,FDA-2020-E-1333,"Patent Term Extension Application for ADAKVEO Patent No 9,556,266",Other,Application,2020-05-01T04:00:00Z,2020,5,2020-05-01T04:00:00Z,,2020-05-01T17:52:08Z,,0,0,090000648452d69a